The Web's First Cancer Resource OncoLink en espanolOncoLink en espanõl

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Quick Search: advanced search
emailPrint | emailEmail | OncoLink - Share Share | Friday, July 30, 2010
Cancer Resources

Cancer Resources > Cancer News > 2000 > November

Reuters

Prostate cancer prognosis with bladder neck involvement better than expected

Last Updated: 2000-09-29 18:08:13 EDT (Reuters Health) - A retrospective review of radical prostatectomy patients indicates that those with bladder neck involvement have a lower risk of disease progression than those with seminal vesicle invasion, Israeli researchers report.

This is contrary to the current tumor, node and metastasis (TNM) classification of prostate cancer, which considers bladder neck involvement a significantly advanced, or stage T4a, disease, while seminal vesicle invasion is classified as T3c disease, Dr. Ofer Yossepowitch and colleagues write in the September issue of Urology.

Dr. Yossepowitch's team, from the Rabin Medical Center, in Petah-Tikva, analyzed pre- and postoperative clinical and pathologic data for 286 consecutive radical prostatectomy patients. The researchers identified 25 patients with pathologic bladder neck involvement and 26 patients with seminal vesicle invasion.

"The overall disease recurrence rate...was 62% in [those with seminal vesicle invasion] and only 36% in the [bladder neck involvement] group," the researchers write. They defined disease progression as a prostate-specific antigen (PSA) level of 0.2 ng/mL and rising.

A mean follow-up of 30.8 months in the bladder neck involvement group showed no progression to metastatic disease. Conversely, during a mean follow up of 40.8 months, 20% of those with seminal vesicle invasion showed metastatic disease progression.

Dr. Yossepowitch's group adds, "It appears that bladder neck involvement in the pathologic specimen does not carry such a dismal prognosis and that seminal vesicle involvement is definitely an ominous prognostic sign."

"Bladder neck involvement in the surgical specimen should not be included with the pathologic T4 subgroup," Dr. Yossepowitch and colleagues conclude. They believe that modification of the TNM staging system should be considered.

Reference

  • Urology 2000;56:448-452.

    See Also:

  • OncoLink: Cancer Metastases

  • OncoLink: Prostate Cancer

  • Add OncoLink News to Palm AvantGo Channels

    «Previous | 1 | Next »

    Copyright © 2010 Reuters Limited. All rights reserved.
    Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.